Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PHM16 |
Synonyms | |
Therapy Description |
PHM16 is an ATP competitive inhibitor of PTK2 (FAK) and FGFR2, which may result in decreased cell adhesion, inhibition of cell growth, and induction of apoptosis (PMID: 24657306, PMID: 26549408). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PHM16 | FAK inhibitor 15 FGFR2 Inhibitor 23 | PHM16 is an ATP competitive inhibitor of PTK2 (FAK) and FGFR2, which may result in decreased cell adhesion, inhibition of cell growth, and induction of apoptosis (PMID: 24657306, PMID: 26549408). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|